Acknowledgements
Wolfram
GILBERT
The authors thank Aramy Forrest, DK Strickland, and Sarah Cannon Development Innovations for their management of study conduct. The authors also thank Wolfram Brugger, MD, PhD, Julie Charlton, PhD, Jon Travers, PhD, and Carrie Adelman, PhD, all of AstraZeneca, for their contributions to the study. Medical writing support for the development of this manuscript, under the direction of the authors, was provided by Susanne Gilbert and Helen Kitchen of Ashfield MedComms (New York, NY and Macclesfield, UK), an Ashfield Health Company, and was funded by AstraZeneca.